Earnings Call · Q1 FY2024·2024-05-08

Q1 24EPS -36.84%·Rev n/aQ4 23EPS +61.82%·Rev n/aQ3 23EPS +100.00%*·Rev n/aQ2 23EPS +100.00%*·Rev n/a⚠ consensus missing

SUPERNUS PHARMACEUTICALS, INC. SUPN

−4.2%1d on move date−4.7% vs SPY3d−5.2%5d−8.2%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SUPN calls or request research access.

More SUPN calls Browse calls Request research access